Sensorion
Created in 2009
Up & running (A)
Existing signals show a regular activitySocial networks
529 7,269Activities
Technologies
Entity types
Location
Rue du Professeur Joseph Anglada, 34090 Montpellier, France
Montpellier
France
Employees
Scale: 11-50
Estimated: 84
SIREN
512757725Engaged catalyst
17
0 0Added in Motherbase
6 years, 7 months ago
Value proposition
Our mission: find solutions for hearing disorders
Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders
Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation.
Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs aimed at correcting hereditary monogenic forms of deafness including OTOF-GT, targeting deafness caused by a mutation of the gene encoding for otoferlin, and hearing loss related to mutation in GJB2 gene to potentially address important hearing loss segments in adults and children (GJB2-GT).
gene therapy, small molecule, and inner earOriginal language
Our mission: find solutions for hearing disorders
Sensorion est une société biotechnologique pionnière au stade clinique dédiée au développement de thérapies innovantes pour restaurer, traiter et prévenir dans le domaine des pertes d’audition
Sensorion - Live Life with Unlimited Connections
Notre mission : trouver des solutions pour les troubles de l’audition. Sensorion est une société de biotechnologie pionnière au stade clinique dédiée au développement de thérapies innovantes pour restaurer, traiter et prévenir les troubles de l’audition, un important besoin médical non-satisfait.
https://www.sensorion.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 28 Feb 2025 | | |
 J.P. Morgan Bank | J.P. Morgan Bank | Other 14 Jan 2025 | | |
 Entreprendre à Montpellier Startup accelerator & VC, Government Administration | Entreprendre à Montpellier Startup accelerator & VC, Government Administration | Other 24 Jul 2024 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 11 May 2024 | | |
 Le Figaro Media, Newspaper Publishing | Le Figaro Media, Newspaper Publishing | Other 15 Feb 2024 | | |
 BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 9 Jan 2025 | | |
 Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Eurobiomed Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 29 Aug 2023 | | |
 UK Atomic Energy Authority Research, National and local authorities | UK Atomic Energy Authority Research, National and local authorities | Other 21 Jul 2023 | | |
 Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix (APHP) Health, Medical Practices | Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix (APHP) Health, Medical Practices | Other 6 Jun 2023 | | |
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 27 Apr 2023 | | |